Anger and Psychotrauma: Data From Military and Civilians

NCT ID: NCT04518267

Last Updated: 2023-04-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-09-21

Study Completion Date

2024-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Post-Traumatic Stress Disorder (PTSD) is mainly associated with several emotions such as anger, guilt or shame. By interfering with psychotherapeutic work these emotions can be problematic. When suffering from PTSD, pervasive anger can also have relational consequences. Anger and PTSD are mutually reinforcing: anger can aggravate PTSD symptoms and aggressive behaviours, and conversely, PTSD promotes high levels of anger and aggression. A few explanatory hypotheses have been proposed. In terms of personality factors, anger-treatment may promote the severity of PTSD symptoms and the development of aggressive behaviours. In terms of stressors, exposure to combat and combat-related moral harms could play a role in the relationship between PTSD, anger and traumatic experiences over the course of life. Finally, in clinical terms, in the presence of PTSD, anger and aggressive behaviours may be triggered by substance abuse and depression.

Within the Anglo-Saxon literature, it is recognized that both civilians and military personnel with PTSD exhibit high levels of anger, with a possible predominance among military personnel. While we know that anger management mechanisms can be strongly influenced by cultural aspects and the type of event, there is no data in the French population.

This study proposes to fill in our knowledge of anger-PSTD relationships in the French population and by comparing civilian and military population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-traumatic Stress Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Civilian group

Participants with civilian status

Structured clinical interview

Intervention Type BEHAVIORAL

A structured clinical interview will be performed at enrollment.

Psychological questionnaires

Intervention Type BEHAVIORAL

Several psychological questionnaires will be performed at enrollment.

Military group

Participants with military status

Structured clinical interview

Intervention Type BEHAVIORAL

A structured clinical interview will be performed at enrollment.

Psychological questionnaires

Intervention Type BEHAVIORAL

Several psychological questionnaires will be performed at enrollment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Structured clinical interview

A structured clinical interview will be performed at enrollment.

Intervention Type BEHAVIORAL

Psychological questionnaires

Several psychological questionnaires will be performed at enrollment.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* To have a PTSD diagnosis
* To be at least 18 years of age

Exclusion Criteria

* To suffer from trauma-related physical condition (including Traumatic Brain Injury)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Direction Centrale du Service de Santé des Armées

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre hospitalier d'Arras

Arras, , France

Site Status RECRUITING

Centre régional psychotrauma Hauts-de-France

Lille, , France

Site Status RECRUITING

3ème Centre médical des Armées

Lille, , France

Site Status RECRUITING

Centre Hospitalier de Cadillac

Lormont, , France

Site Status NOT_YET_RECRUITING

CHU de Nice

Nice, , France

Site Status RECRUITING

CHU-Lenval hôpitaux

Nice, , France

Site Status RECRUITING

Centre Hospitalier Léon-Jean Grégory de Thuir

Thuir, , France

Site Status NOT_YET_RECRUITING

Groupe Hospitalier Paul Guiraud

Villejuif, , France

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Anaïs MARMUSE

Role: CONTACT

328382250 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Laure ROUGEGREZ, MD

Role: primary

321211070 ext. +33

Frédérique WAREMBOURG, MD

Role: primary

320445557 ext. +33

Anais MARMUSE

Role: primary

328382250 ext. +33

Samantha AL JOBOORY, MD

Role: primary

Jérémy BRIDE

Role: primary

692033335 ext. +33

Morgane GINDT

Role: primary

492030066 ext. +33

Philippe RAYNAUD, MD

Role: primary

468846620 ext. +33

Claire GRANIER, MD

Role: primary

142117230 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-A00507-32

Identifier Type: OTHER

Identifier Source: secondary_id

2019PPRC16

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.